PATIENT LABELING FOR PROSCAR, FOSAMAX "COME CLOSEST TO SATISFYING" CONSUMER NEEDS IN FILLING CONSUMER ADS "BRIEF SUMMARY" REQUIREMENT -- AARP

Patient labeling for Merck's prostate therapy Proscar and its osteoporosis treatment Fosamax "come closest to satisfying" consumer needs, the American Association of Retired Persons says in response to FDA's call for comments on its intent to consider agency-approved patient labeling as adequate to fulfill the "brief summary" requirement in direct-to-consumer advertising.